Clinical Trial

Study of Molecular Characterisation of Early Operable Primary Breast Cancer in Pakistani Population

Study acronym: BrCa
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 13, 2025 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study is looking at the biological characteristics of early operable primary breast cancer in Pakistani Population by using IHC
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-02-11.
Trial Details
NCT Number NCT06830590
Lead Sponsor Liaquat University of Medical & Health Sciences
Conditions Breast Cancer, Molecular Pathway Deregulation, Treatment
Enrollment 300 participants
Start Date 2016-02-01
Primary Completion 2025-12-30 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-08-13